Eurofarma Ventures
Est. dry powder
$43.1M
Raised, not yet invested
AUM
—
Not reported
Latest fund
$30M
Neuron Ventures II
Est. cheque size
$475K–
From fund sizes
Deals, last 12 months
2
Last seen investing Aug 2026
About Eurofarma Ventures
Eurofarma Ventures is a corporate venture capital arm of a Brazilian pharmaceutical company, Eurofarma, that invests in early-stage biotech companies specializing in drug research and development and gene therapy, focusing mainly on the US and Europe.
- Type
- Venture Capital Firm
- Headquarters
- Sao Paulo, Sao Paulo, Brazil
- Stages
- SeedSeries ASeries BSeries DEarly Stage
- Est. cheque size
- $475K–$4.1M
- Sectors
- Healthcare, Information Technology
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series B2
- Seed1
- Series A1
- Series D1
Across 5 deals
Portfolio sectors
- Biotechnology4
Across 4 companies
Portfolio countries
- US3
- Brazil1
Across 4 companies
Recent investments
Newest 5 of 5
- Series D$39.4M
Abcuro, Inc.
Aug 2026 · Series D
- Series A$47.5M
PsiThera, Inc.
Dec 2025 · Series A
- Seed$1.3M
Gen-T
Oct 2023 · Seed
- Series B$120.1M
Abcuro, Inc.
Aug 2023 · Series B
- Series B$72M
Rome Therapeutics, Inc.
Jun 2023 · Series B
Offices
1 location
- Sao Paulo, Sao Paulo, BrazilHQ
Questions about Eurofarma Ventures
How much does Eurofarma Ventures invest per deal?
Based on the size of its funds, Eurofarma Ventures writes estimated cheques of $475K–$4.1M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Eurofarma Ventures invest in?
Eurofarma Ventures has invested at Seed, Series A, Series B, Series D and Early Stage. Its most frequent rounds on record are Series B, Seed and Series A.
How much capital does Eurofarma Ventures have left to invest?
Eurofarma Ventures has an estimated $43.1M in dry powder: capital it has raised but not yet invested.